Rapid diagnosis and treatment of infectious diseases are critical to both the patient and the broader community. ENACT (Early Notification to Act, Control, and Treat) partners with innovators to develop disruptive technologies that detect, prognosticate outcomes, and enable early intervention following exposures to both natural and man-made infectious threats. To learn more about the ENACT program, please see more on the ENACT Program Factsheet.
Watch an introduction to the program, presented to the Digital Medicine Society on September 9, 2020
ENACT endeavors to upend the traditional doctor-patient paradigm by empowering patients, health-care providers, and public health organizations with early and actionable health status information. By supporting the development of novel sensors and data analytics approaches, ENACT aims to provide information that enables early indication of infection, reduces illness spread in an epidemic, enables faster diagnostics, improves adherence monitoring and intervention in clinical trials, and efficiently allocates medical resources.
ENACT helps develop accessible technological solutions that provide early and actionable health status information to empower the individual, health-care provider, and public health organizations to rapidly act, control, and treat infectious diseases. To this end, ENACT partners with academic and private sector teams to support research and development of novel physiological sensors, telehealth, and data analytics platforms.